Do You Have to Take Wegovy Forever?

What actually happens when you stop taking Wegovy?

This is the question most people are really asking. In the STEP 1 trial, published in the New England Journal of Medicine, participants taking semaglutide 2.4mg lost around 15% of their body weight on average over 68 weeks. A follow-up study then withdrew treatment: within a year of stopping, participants had regained roughly two-thirds of what they had lost, and the health markers that had improved largely returned to baseline too.

That is not a failure of the medicine. It reflects something important about obesity as a biological condition. Appetite regulation involves multiple hormonal signals, and semaglutide works by reinforcing the GLP-1 pathway that tells your brain you have eaten enough. Remove that signal and the underlying biology reasserts itself. The NHS semaglutide page notes that weight management medicines work best alongside lasting changes to diet and activity, but that combination still does not guarantee maintained loss after stopping for everyone.

This does not mean you are committed to injecting forever, and if you are weighing that up it is worth reading our page on whether you have to stay on Wegovy forever. It means that stopping is a decision worth making carefully, with a clear plan, rather than simply running out of pens and seeing what happens.

The NHS two-year limit, and what it means for you

If you have heard that semaglutide should only be taken for two years, that guidance comes from NICE's appraisal of Wegovy (TA875), which recommends its use within NHS specialist weight management services for a maximum of two years. NICE reached that position partly on cost-effectiveness grounds specific to NHS commissioning, and partly because the long-term trial evidence at the time of appraisal extended to around two years.

The two-year ceiling applies to the NHS route. Private prescribing follows the licensed indications in the medicine's SmPC, which does not set a fixed duration. Whether to continue beyond two years is a clinical conversation weighing your individual benefits, any side effects and your wider health picture. Some people will have achieved stable weight and feel ready to stop. Others will have ongoing health conditions that were genuinely improved by treatment. There is no universal answer, which is exactly why a prescriber (rather than a blanket rule) should be driving that decision.

If cost is part of what you are weighing up, our Wegovy pricing page sets out what private treatment involves transparently, including what is covered and how billing works.

Can you take Wegovy indefinitely if it is helping?

There is no licence restriction on duration for adults who meet the eligibility criteria and are responding well to treatment, and our page on whether you can take Wegovy forever goes into this in more detail. The question is whether continuing remains clinically appropriate for you specifically. Prescribers look at whether weight loss is being maintained, whether side effects are tolerable, whether the original weight-related condition has improved, and whether anything in your health has changed that affects suitability.

This is where the structure of private prescribing at a service like ours matters practically. Every repeat order at our Wegovy service involves a clinical re-assessment by a GPhC-registered prescriber. It is not a rubber stamp, a real clinician reads your updated answers before anything is approved. So if your circumstances shift, that gets picked up. The NHS England weight management guidance also highlights that ongoing clinical support is part of responsible long-term use of these medicines.

One practical note: many people taking Wegovy long-term tell our prescribers they keep the pen in the fridge door, just part of the weekly routine. That normalisation is a reasonable thing, treatment for a chronic condition should not feel like a crisis every week.

Planning an exit: stopping without a crash

If you do decide to stop, the evidence suggests that how you stop matters. Abrupt discontinuation after a high maintenance dose is more likely to lead to rapid return of appetite than a planned taper, though you should discuss the approach with your prescriber rather than self-managing the schedule. Maintaining the dietary habits and activity built during treatment gives you the best chance of retaining some of what you achieved, and catching regain early, before it fully reverses your progress, is easier than starting over.

Some people find semaglutide was always intended as a fixed-duration tool: lose weight, use the window to build sustainable habits, then stop with a plan. Others reach a maintenance dose and stay there for years because the health benefit is clear and ongoing. Both are legitimate paths. How well semaglutide works for you individually also shapes how long continuing makes sense. The honest position is that the right duration is personal, and the right person to help you decide is a prescriber who knows your full picture.